BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18184044)

  • 1. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets.
    Ye Z; Huang H; Hao S; Xu S; Yu H; Van Den Hurk S; Xiang J
    J Interferon Cytokine Res; 2007 Dec; 27(12):1031-8. PubMed ID: 18184044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
    Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
    J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
    Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
    Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
    Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
    Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
    Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
    Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells.
    Carbonneil C; Saidi H; Donkova-Petrini V; Weiss L
    Int Immunol; 2004 Jul; 16(7):1037-52. PubMed ID: 15184347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.